company background image
GMVD

G Medical Innovations Holdings NasdaqCM:GMVD Stock Report

Last Price

US$0.38

Market Cap

US$9.1m

7D

-4.4%

1Y

-85.5%

Updated

10 Aug, 2022

Data

Company Financials +
GMVD fundamental analysis
Snowflake Score
Valuation0/6
Future Growth3/6
Past Performance0/6
Financial Health2/6
Dividends0/6

GMVD Stock Overview

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel.

G Medical Innovations Holdings Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for G Medical Innovations Holdings
Historical stock prices
Current Share PriceUS$0.38
52 Week HighUS$6.74
52 Week LowUS$0.32
Beta-1.34
1 Month Change-59.50%
3 Month Change-48.22%
1 Year Change-85.54%
3 Year Changen/a
5 Year Changen/a
Change since IPO-69.76%

Recent News & Updates

Shareholder Returns

GMVDUS HealthcareUS Market
7D-4.4%1.8%0.3%
1Y-85.5%14.3%-13.5%

Return vs Industry: GMVD underperformed the US Healthcare industry which returned 14.3% over the past year.

Return vs Market: GMVD underperformed the US Market which returned -13.5% over the past year.

Price Volatility

Is GMVD's price volatile compared to industry and market?
GMVD volatility
GMVD Average Weekly Movement36.4%
Healthcare Industry Average Movement9.0%
Market Average Movement7.9%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.2%

Stable Share Price: GMVD is more volatile than 90% of US stocks over the past 3 months, typically moving +/- 36% a week.

Volatility Over Time: GMVD's weekly volatility has increased from 23% to 36% over the past year.

About the Company

FoundedEmployeesCEOWebsite
2014n/aYacov Gevahttps://gmedinnovations.com

G Medical Innovations Holdings Ltd, together with its subsidiaries, an early commercial stage healthcare company, engages in the development of next generation mobile health and telemedicine solutions in the United States, China, and Israel. The company’s products include Prizma, a plug-and-play medical device that measures vital signs with electronic medical records functionality and clinical grade reporting standards; and Extended Holter Patch System, a multi-channel patient-worn biosensor that captures electrocardiogram data continuously for up to 14 days. It also develops Wireless Vital Signs Monitoring System, a solution that provides continuous real time monitoring of vital signs and biometrics.

G Medical Innovations Holdings Ltd Fundamentals Summary

How do G Medical Innovations Holdings's earnings and revenue compare to its market cap?
GMVD fundamental statistics
Market CapUS$9.14m
Earnings (TTM)-US$14.76m
Revenue (TTM)US$5.06m

1.8x

P/S Ratio

-0.6x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
GMVD income statement (TTM)
RevenueUS$5.06m
Cost of RevenueUS$3.56m
Gross ProfitUS$1.50m
Other ExpensesUS$16.26m
Earnings-US$14.76m

Last Reported Earnings

Dec 31, 2021

Next Earnings Date

n/a

Earnings per share (EPS)-0.61
Gross Margin29.70%
Net Profit Margin-291.78%
Debt/Equity Ratio-286.5%

How did GMVD perform over the long term?

See historical performance and comparison